aod9604 igf-1 effects AOD‑9604 Fat Loss Research in 2025: Late‑Night Hype, Quiet Data, and What Real People Actually Feel AOD-9604 (HGH Fragment 176-191) —

How long should I run an AOD-9604 cycle

AOD-9604 has demonstrated excellent safety and tolerability in six randomized controlled trials involving over 900 participants

This timing aligns with natural fat metabolism cycles and allows the peptide to work throughout the day when metabolic activity is highest

Intramuscular injection places it directly in muscle tissue

Studies involving approximately 900 participants consistently demonstrated fat loss without changes in IGF-1, preserved glucose homeostasis despite fat reduction, absence of anabolic tissue growth effects, and safety profile comparable to placebo

Dosing tiers: Start at 250 mcg on the first injection to assess tolerance